PRNB - Principia Biopharma Inc. - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Pharmaceutical Preparations - PRNB (1510487)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
Real-time CSV, Options, Alerts
31 results - Yahoo - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Insider Name

Insider Title

Trade Type 

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

D
2020-09-18
PRNBHardiman Roy C.Chief Business OfficerS - Sale+OE$99.98-5,000119,677-4%-$499,918
D
2020-08-18
PRNBThomas DolcaChief Medical OfficerS - Sale+OE$100.00-15,0001,826-89%-$1,500,000
D
2020-08-18
PRNBChai Christopher YCFOS - Sale+OE$99.37-7,5006,841-52%-$745,240
D
2020-08-10
PRNBGoldstein David MChief Scientific OfficerS - Sale+OE$88.61-6,00031,739-16%-$531,665
D
2020-07-15
PRNBThomas DolcaChief Medical OfficerS - Sale+OE$80.07-15,0001,826-89%-$1,201,070
D
2020-07-01
PRNBColowick AlanDirS - Sale+OE$60.00-7,5000-100%-$450,000
D
2020-06-23
PRNBBabler MartinPres, CEOS - Sale+OE$61.86-15,00058,344-20%-$927,889
2020-06-15
PRNBWolff StefaniChief Development OfficerS - Sale$60.75-5,50419,096-22%-$334,385
A
2020-03-16
PRNBWolff StefaniChief Development OfficerS - Sale$46.15-5,50424,600-18%-$254,031
A
2019-12-16
PRNBWolff StefaniChief Development OfficerS - Sale$49.43-5,50530,104-15%-$272,091
D
2020-06-12
PRNBHardiman Roy C.Chief Business OfficerS - Sale+OE$61.16-5,000119,677-4%-$305,788
D
2020-05-19
PRNBChai Christopher YCFOS - Sale+OE$65.10-7,5006,841-52%-$488,268
D
2020-05-07
PRNBGoldstein David MChief Scientific OfficerS - Sale+OE$60.16-6,00030,968-16%-$360,941
DM
2020-05-01
PRNBColowick AlanDirS - Sale+OE$60.01-7,5000-100%-$450,057
D
2020-03-16
PRNBWolff StefaniChief Development OfficerS - Sale+OE$46.15-5,50435,609-13%-$254,031
D
2020-03-13
PRNBHardiman Roy C.Chief Business OfficerS - Sale+OE$48.56-5,000118,819-4%-$242,816
D
2020-03-03
PRNBBabler MartinPres, CEOS - Sale+OE$63.47-15,00039,179-28%-$952,083
D
2020-02-18
PRNBChai Christopher YCFOS - Sale+OE$65.89-7,5008,068-48%-$494,186
D
2020-02-10
PRNBGoldstein DavidChief Scientific OfficerS - Sale+OE$70.90-6,00030,968-16%-$425,400
2019-12-19
PRNBThomas DolcaChief Medical OfficerS - Sale$60.00-495494-50%-$29,700
M
2019-12-17
PRNBBabler MartinPres, CEOS - Sale$53.07-29,50018,355-62%-$1,565,455
D
2019-12-16
PRNBWolff StefaniChief Development OfficerS - Sale+OE$49.43-5,50535,609-13%-$272,091
D
2019-12-13
PRNBHardiman Roy C.Chief Business OfficerS - Sale+OE$49.41-5,000121,519-4%-$247,034
2019-11-20
PRNBBecker Daniel J.DirP - Purchase$29.94+55,000667,600+9%+$1,646,700
D
2019-11-07
PRNBGoldstein DavidChief Scientific OfficerS - Sale+OE$32.39-10,00029,819-25%-$323,914
M
2019-10-28
PRNBBecker Daniel J.DirP - Purchase$33.48+77,600612,600+15%+$2,598,026
2019-10-18
PRNBGlaxosmithkline PlcFormer 10% OwnerP - Purchase$28.00+357,1422,982,855+14%+$9,999,976
2019-10-18
PRNBGeorge SimeonDirP - Purchase$28.00+357,1422,982,855+14%+$9,999,976
2019-10-18
PRNBBecker Daniel J.DirP - Purchase$28.00+535,000535,000New+$14,980,000
2019-08-13
PRNBNew Leaf Ventures Ii, L.P.10%S - Sale$35.00-300,000387,546-44%-$10,500,000
2019-05-21
PRNBOrbimed Advisors LLC10%S - Sale$30.25-1,000,0001,605,713-38%-$30,250,000
AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top